Division of Hematology and Oncology, Sickle Cell Center, University of Illinois at Chicago, Chicago, Illinois, USA.
Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.
Br J Haematol. 2024 Jul;205(1):316-319. doi: 10.1111/bjh.19525. Epub 2024 May 12.
The pathophysiology and genetic risk for sickle cell disease (SCD)-related chronic kidney disease (CKD) are not well understood. In 70 adults with SCD-related CKD and without APOL1 inherited in a high-risk pattern, 24 (34%) had pathogenic variants in candidate genes using KidneySeq™. A moderate impact INF2 variant was observed in 20 (29%) patients and those with 3 versus 0-2 pathogenic or moderate impact glomerular genetic variants had higher albuminuria and lower estimated glomerular filtration rate (adjusted p ≤ 0.015). Using a panel of preselected genes implicated in kidney health, we observed several variants in people with sickle cell nephropathy.
镰状细胞病(SCD)相关慢性肾脏病(CKD)的病理生理学和遗传风险尚不清楚。在 70 名患有 SCD 相关 CKD 且未携带高风险模式的 APOL1 遗传的成年人中,使用 KidneySeq™ 在 24 名(34%)患者中发现候选基因中的致病性变异。在 20 名(29%)患者中观察到中度影响 INF2 变异,与 0-2 种致病性或中度影响肾小球遗传变异相比,具有 3 种致病性或中度影响肾小球遗传变异的患者蛋白尿更高,估算肾小球滤过率(调整后 p≤0.015)更低。使用一组预先选定的与肾脏健康相关的基因进行检测,我们在镰状细胞肾病患者中观察到了几种变异。